Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A-Reference-Cited by-同舟云学术

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A

Published:2013-05-10 Issue:1 Volume:58 Page:75-85
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Romeu Belkis,Lastre Miriam,García Luis,Cedré Bárbara,Mandariote Aleida,Fariñas Mildrey,Oliva Reynaldo,Pérez Oliver

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-013-8427-6.pdf

Reference46 articles.

1. Weintraub A. Immunology of bacterial polysaccharide antigens. Carb Res. 2003;338:2539–47.

2. Wing J, Smart L, Borrow R, Findlow J, Findlow H, Lees A, Read RC, et al. Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity. PLoS ONE. 2012;7:e31160.

3. Ambrosino DM, Sood SK, Lee MC, Chen D, Collard HR, Bolon DL, Johnson C, et al. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants. Pediatr Infect Dis J. 1992;11:855–9.

4. Borrow R, Southern J, Andrews N, Peake N, Rahim R, Acuna M, Martin S, et al. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls. Vaccine. 2001;19:3043–50.

5. Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis. 1998;177:1112–5.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring;Human Vaccines & Immunotherapeutics;2024-05-15

2. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens;Applied Microbiology and Biotechnology;2024-02-24

3. Microbial Extracellular Vesicles in Host-Microbiota Interactions;Results and Problems in Cell Differentiation;2024

4. Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities;iMeta;2023-02-06

5. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy;Advanced Drug Delivery Reviews;2022-07